摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl cyclohexanecarboximidate | 66493-03-6

中文名称
——
中文别名
——
英文名称
methyl cyclohexanecarboximidate
英文别名
methyl cyclohexanecarbimidate
methyl cyclohexanecarboximidate化学式
CAS
66493-03-6
化学式
C8H15NO
mdl
——
分子量
141.213
InChiKey
LISVYUBFCHWPDZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    174.4±23.0 °C(Predicted)
  • 密度:
    1.04±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    10
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.88
  • 拓扑面积:
    33.1
  • 氢给体数:
    1
  • 氢受体数:
    2

反应信息

点击查看最新优质反应信息

文献信息

  • PYRIMIDINES AND PYRIDINES USEFUL AS INHIBITORS OF PROTEIN KINASES
    申请人:Henkel Gregory William
    公开号:US20110224197A1
    公开(公告)日:2011-09-15
    The present invention relates to compounds useful as inhibitors of protein kinases, such as inhibitors of GSK-3. The invention provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders. The invention provides processes for preparing compounds of the invention. The invention provides methods of identifying compounds useful for treatment of diabetes, diabetic neuropathy, osteoporosis, Alzheimer's disease, Huntington's disease, Parkinson's disease, AIDS-associated dementia, bipolar disorder, amyotrophic lateral sclerosis, multiple sclerosis, schizophrenia, leukocytopenia, cardiomyocyte hypertrophy, stroke, post-stroke, spinal cord injury, traumatic brain injury, Charcot-Marie-Tooth, peripheral nerve regeneration, and rheumatoid arthritis.
    本发明涉及一种作为蛋白激酶抑制剂的化合物,例如GSK-3的抑制剂。本发明提供了包含本发明化合物的药学上可接受的组合物,并提供了使用这些组合物治疗各种疾病的方法。本发明提供了制备本发明化合物的方法。本发明提供了鉴定用于治疗糖尿病、糖尿病神经病变、骨质疏松症、阿尔茨海默病、亨廷顿病、帕金森病、艾滋病相关痴呆、双相情感障碍、肌萎缩性侧索硬化、多发性硬化症、精神分裂症、白细胞减少症、心肌细胞肥大、中风、中风后、脊髓损伤、创伤性脑损伤、沙科-玛丽-图特病、周围神经再生和类风湿性关节炎的化合物的方法。
  • AMINOPYRIMIDINES USEFUL AS INHIBITORS OF PROTEIN KINASES
    申请人:Vertex Pharmaceuticals Incorporated
    公开号:US20140194444A1
    公开(公告)日:2014-07-10
    The present invention relates to compounds useful as inhibitors of protein kinases. The invention also provides pharmaceutically acceptable compositions comprising those compounds and methods of using the compounds and compositions in the treatment of various disease, conditions, and disorders. The invention also provides processes for preparing compounds of the invention.
    本发明涉及一种作为蛋白激酶抑制剂有用的化合物。本发明还提供了包含这些化合物的药学上可接受的组合物,以及使用这些化合物和组合物治疗各种疾病、病况和疾病的方法。本发明还提供了制备本发明化合物的方法。
  • Substituted N-methylene derivatives of thienamycin sulfoxide and sulfone and their preparation
    申请人:Merck & Co., Inc.
    公开号:EP0001264A1
    公开(公告)日:1979-04-04
    Disclosed are substituted N-methylene derivatives of thienamycin sulfoxide (1, n=1) and sulfone (I, n=2) which may be represented by the following structural formula: wherein X and Y are selected from the group consisting of hydrogen, R, OR, SR, and NR' R2 wherein, inter alia, R is substituted or unsubstituted: alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, aryl, aralkyl, heteroaryl, heteroaralkyl, heterocyclyl, and heterocyclylalkyl; R1 and R2 are hydrogen or R. Such compounds and their pharmaceutically acceptable salt, ether, ester and amide derivatives are useful as antibiotics. Also disclosed are processes for the preparation of such compounds; pharmaceutical compositions comprising such compounds; and methods of treatment comprising administering such compounds and compositions when an antibiotic effect is indicated.
    本发明公开了噻喃霉素亚砜(1,n=1)和砜(I,n=2)的取代 N-亚甲基衍生物,其结构式如下: 其中 X 和 Y 选自由氢、R、OR、SR 和 NR' R2 组成的组,其中除其他外,R 是取代或未取代的:烷基、烯基、炔基、环烷基、环烷基烷基、芳基、芳烷基、杂芳基、杂芳基烷基、杂环烷基和杂环烷基;R1 和 R2 是氢或 R。此类化合物及其药学上可接受的盐、醚、酯和酰胺衍生物可用作抗生素。此外,还公开了制备此类化合物的工艺;包含此类化合物的药物组合物;以及治疗方法,包括在需要抗生素效果时施用此类化合物和组合物。
  • Chihaoui,M.; Baccar,B., Comptes Rendus des Seances de l'Academie des Sciences, Serie C: Sciences Chimiques, 1978, vol. 287, p. 69 - 72
    作者:Chihaoui,M.、Baccar,B.
    DOI:——
    日期:——
  • WO2008/112642
    申请人:——
    公开号:——
    公开(公告)日:——
查看更多